Michael Fitzgerald
Seattle University(US)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Multiple Myeloma Research and Treatments, Immune Cell Function and Interaction, T-cell and B-cell Immunology, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer(2010)490 cited
- → Development of a Catalytic Enantioselective Conjugate Addition of 1,3-Dicarbonyl Compounds to Nitroalkenes for the Synthesis of Endothelin-A Antagonist ABT-546. Scope, Mechanism, and Further Application to the Synthesis of the Antidepressant Rolipram(2002)209 cited
- → Mobocertinib (TAK-788): A Targeted Inhibitor of EGFR Exon 20 Insertion Mutants in Non–Small Cell Lung Cancer(2021)190 cited
- → Synthesis and Biological Evaluation of 2-Indolyloxazolines as a New Class of Tubulin Polymerization Inhibitors. Discovery of A-289099 as an Orally Active Antitumor Agent(2002)123 cited
- → Phosphorylated RPA recruits PALB2 to stalled DNA replication forks to facilitate fork recovery(2014)107 cited
- → Antitumor Activity of the Investigational Proteasome Inhibitor MLN9708 in Mouse Models of B-cell and Plasma Cell Malignancies(2011)106 cited
- → PKC-θ-Deficient Mice Are Protected from Th1-Dependent Antigen-Induced Arthritis(2006)105 cited
- → Recombinant Human Interleukin-11 Directly Promotes Megakaryocytopoiesis In Vitro(1997)74 cited
- → Mice deficient in PKC theta demonstrate impairedin vivoT cell activation and protection from T cell-mediated inflammatory diseases(2006)69 cited
- → Targeting HER2 Exon 20 Insertion–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib(2021)55 cited